Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia
I
Inna M. Chen
J
Julia S. Johansen
S
Susann Theile
(Department of Oncology, Herlev and Gentofte Hospital, Herlev, Copenhagen, Denmark)
L
Libbie M. Silverman
K
Katherine R. Pelz
K
Kasper Madsen
O
Olav Dajani
K
Kevin Z.M. Lim
T
Torben Lorentzen
O
Omnia Gaafer
L
Leonidas G. Koniaris
A
Anna C. Ferreira
B
Brian Neelon
(Medical University of South Carolina, Charleston, South Carolina, United States)
D
Denis C. Guttridge
M
Michael C. Ostrowski
(Department of Biochemistry and Molecular Biology and Hollings Cancer Center, Medical University of South Carolina)
T
Teresa A. Zimmers
D
Dorte Nielsen
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 25
Published
September 01, 2025
Pages
2840-2840
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (17)
I
Inna M. Chen
J
Julia S. Johansen
S
Susann Theile
Department of Oncology, Herlev and Gentofte Hospital, Herlev, Copenhagen, Denmark
L
Libbie M. Silverman
K
Katherine R. Pelz
K
Kasper Madsen
O
Olav Dajani
K
Kevin Z.M. Lim
T
Torben Lorentzen
O
Omnia Gaafer
L
Leonidas G. Koniaris
A
Anna C. Ferreira
B
Brian Neelon
Medical University of South Carolina, Charleston, South Carolina, United States
D
Denis C. Guttridge
M
Michael C. Ostrowski
Department of Biochemistry and Molecular Biology and Hollings Cancer Center, Medical University of South Carolina
T
Teresa A. Zimmers
D
Dorte Nielsen
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001